Shuttle Pharmaceuticals Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company utilizing proprietary technology to develop novel therapies. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy. While there are several therapies being developed with the goal of curing cancer, one of the most effective and proven approaches to this is radiation therapy (RT).

Top 100 in Pharmaceutical in United States
Top 100 in Therapeutics in United States
Company Highlights
Year Founded

2012

icon-altEmployees

8

Location (HQ)

USA

Since Last Funding

1 year 11 months

Monthly Website Visitors

1.3K

icon-altTotal Investment Amt

$4.9M

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Biotechnology Research

Biotechnology

Therapeutics

Pharmaceutical